Wegovy, Saxenda and Zepbound are approved for weight loss in the following individuals: Adults with an initial BMI of 30, defined as obesity Adults with an initial BMI of 27, defined as overweight, with at least one weight-related comorbid condition Weight-related comorbid conditions include high blood pressure, cardiovascular disease (such as coronary artery disease, heart attack or heart failure), high cholesterol, obstructive sleep apnea, type 2 diabetes, fatty liver, GERD/acid reflux, osteoarthritis, urinary incontinence, etc
For millions of people who struggle with weight, food was wired in as a coping strategy to deal with lifes circumstances
Frequency depends on your baseline, goals, and response
death from cardiovascular disease
For severe cases, consult a dermatologist for prescription options like antibiotics or retinoids